Bulletin
Investor Alert

Editas Medicine Inc.

NAS: EDIT

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Editas Medicine Inc.

After Hours

EDIT
/zigman2/quotes/200426846/composite

$

10.73

Change

-0.04 -0.37%

Volume

Volume 26,029

Dec 1, 2023, 7:55 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200426846/composite

Previous close

$ 10.53

$ 10.77

Change

+0.24 +2.28%

Day low

Day high

$10.31

$10.85

Open
Open: 10.61

52 week low

52 week high

$6.08

$11.93

Open

Market cap

$860.02M

Average volume

1.80M

P/E ratio

N/A

Rev. per Employee

$108,894

EPS

-2.71

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/edit

MarketWatch News on EDIT

  1. These Gene-Editing Stocks Are Survivors. Take Another Look.

    9:14 a.m. Oct. 25, 2023

    - Barron's Online

  2. Editas Medicine upgraded to neutral from underweight at J.P. Morgan

    5:17 a.m. Oct. 18, 2023

    - Tomi Kilgore

  3. Editas Medicine upgraded to buy from hold at Stifel

    5:47 a.m. Sept. 29, 2023

    - Tomi Kilgore

  4. Gene Editing Is Working. Wall Street Is Taking Notice.

    10:02 a.m. June 16, 2023

    - Barron's Online

  5. Editas Medicine upgraded to outperform at Raymond James

    5:20 a.m. June 13, 2023

    - Tomi Kilgore

  9. Editas Medicine downgraded to perform from outperform at Oppenheimer

    7:27 a.m. Nov. 18, 2022

    - Tomi Kilgore

  10. Editas Medicine stock price target cut to $35 from $80 at Truist

    7:08 a.m. Nov. 18, 2022

    - Tomi Kilgore

  11. Editas Medicine started at neutral with $18 stock price target at BofA Securities

    9:16 a.m. Sept. 29, 2022

    - Tomi Kilgore

  13. Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead

    3:25 p.m. June 23, 2022

    - Barron's Online

  16. Editas Medicine stock price target cut to $19 from $46 at Stifel Nicolaus

    7:05 a.m. Feb. 25, 2022

    - Tomi Kilgore

  19. bluebird bio Has Good News on Its Gene Therapies

    12:16 p.m. Dec. 13, 2021

    - Barron's Online

  20. Beam Gets FDA Nod for First Gene-Editing Trial

    8:10 a.m. Nov. 9, 2021

    - Barron's Online

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/edit

Other News on EDIT

  1. 10-K: EDITAS MEDICINE, INC.

    4:46 p.m. Feb. 22, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. This Insider Just Sold Shares of Editas Medicine Inc

    12:30 p.m. Feb. 16, 2023

    - GuruFocus.com

  5. Here's Why Editas (EDIT) Looks Ripe for Bottom Fishing

    9:55 a.m. Nov. 23, 2022

    - Zacks.com

  8. Editas Medicine, Inc. (EDIT) Q3 2022 Earnings Call Transcript

    9:50 a.m. Nov. 2, 2022

    - Seeking Alpha

  12. Amgen (AMGN) to Report Q3 Earnings: What's in the Cards?

    11:48 a.m. Oct. 31, 2022

    - Zacks.com

/news/pressrelease/company/us/edit

Press Releases on EDIT

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.